Breast Cancer Clinical Trial

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Summary

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Must be at least 2 years postmenopausal
Osteoporotic subjects without vertebral fracture who meet BMD criteria, or Osteoporotic subjects with vertebral fracture

Exclusion Criteria:

Diseases that may affect bone metabolism
Vasomotor symptoms requiring treatment
Known history or suspected cancer of the breast
Active or past history of venous thromboembolic events

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

7609

Study ID:

NCT00205777

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 334 Locations for this study

See Locations Near You

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

7609

Study ID:

NCT00205777

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider